BCG vaccine

E104005

The BCG vaccine is a widely used immunization that primarily protects against severe forms of tuberculosis, especially in young children.

All labels observed (4)

Label Occurrences
BCG vaccine canonical 5
Bacillus Calmette–Guérin vaccine 2
BCG 1

How this entity was disambiguated

Statements (47)

Predicate Object
instanceOf tuberculosis vaccine ⓘ
vaccine ⓘ
abbreviation BCG ⓘ
linked to: BCG vaccine
alsoUsedFor treatment of non–muscle-invasive bladder cancer ⓘ
boosterRecommendation no routine booster recommended by WHO ⓘ
commonSideEffect local injection site reaction ⓘ
permanent scar at injection site ⓘ
small ulcer at injection site ⓘ
contraindication severe immunodeficiency ⓘ
symptomatic HIV infection in infants ⓘ
derivedFrom Mycobacterium bovis ⓘ
developedAt Pasteur Institute of Lille ⓘ
developedBy Albert Calmette ⓘ
Camille Guérin ⓘ
developmentStartYear 1908 ⓘ
doesNotAffect interferon-gamma release assay results significantly ⓘ
dosingSchedule single dose at birth in high-burden countries ⓘ
effectOnTBTests can cause false-positive tuberculin skin test ⓘ
efficacyRangePulmonaryTBAdults 0–80 percent in studies ⓘ
efficacyVariation varies by geography and population ⓘ
firstUsedInHumansYear 1921 ⓘ
formulation lyophilized powder for reconstitution ⓘ
fullName Bacillus Calmette–Guérin vaccine ⓘ
linked to: BCG vaccine
globalUse one of the most widely used vaccines worldwide ⓘ
highEfficacyFor prevention of severe childhood TB forms ⓘ
includedIn many national immunization programs ⓘ
mechanismInBladderCancer stimulates local immune response in bladder ⓘ
notRoutinelyRecommendedIn countries with low tuberculosis incidence ⓘ
organismType live attenuated bacterium ⓘ
primaryUse prevention of tuberculosis ⓘ
protectsAgainst Mycobacterium tuberculosis infection ⓘ
miliary tuberculosis ⓘ
tuberculous meningitis ⓘ
protectsBestAgainst severe forms of tuberculosis in children ⓘ
recommendedBy World Health Organization ⓘ
recommendedIn countries with high tuberculosis prevalence ⓘ
researchArea non-specific immune effects ⓘ
potential protection against other infections ⓘ
routeOfAdministration intradermal injection ⓘ
seriousAdverseEvent disseminated BCG infection in severely immunocompromised individuals ⓘ
storageCondition refrigerated ⓘ
strainType attenuated strain of Mycobacterium bovis ⓘ
targetPopulation infants ⓘ
newborns ⓘ
young children ⓘ
typicalInjectionSite upper arm ⓘ
WHOModelListStatus included in WHO Model List of Essential Medicines ⓘ

How these facts were elicited

Referenced by (9)

Full triples — surface form annotated when it differs from this entity's canonical label.

Expanded Programme on Immunization → usesVaccine → BCG vaccine ⓘ
subject linked to: EPI
BCG vaccine → fullName → Bacillus Calmette–Guérin vaccine ⓘ
linked to: BCG vaccine
BCG vaccine → abbreviation → BCG ⓘ
linked to: BCG vaccine
Institut Pasteur → developed → BCG vaccine (with collaborators) ⓘ
linked to: BCG vaccine
Albert Calmette → coDeveloperOf → BCG vaccine ⓘ
Albert Calmette → developed → BCG vaccine ⓘ
Mycobacterium bovis → basisOf → BCG vaccine ⓘ
Camille Guérin → coDeveloperOf → Bacillus Calmette–Guérin vaccine ⓘ
linked to: BCG vaccine
Camille Guérin → notableWork → BCG vaccine ⓘ